MissionIR Articles
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-CBD(TM) Demonstrates Enhanced Performance Compared to Leading Anti-Seizure Medication
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its patented DehydraTECH-CBD(TM) has demonstrated performance enhancements compared to one of the world’s leading anti-seizure medications, Epidiolex(R). According to the…
-
MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Confirms Inhalation Concept of NanoAb as Therapy for COVID-19
BiondVax (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. The company today announced statistically significant (p<0.001) efficacy results in…
-
Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) Carries Out Exploratory Drilling Work at Iska Iska Project; Receives Mention by Brent Cook as Showing ‘Great Potential’
The discovery of Bolivia’s Potosi silver mine in 1545 was a matter of chance. Don Diego Gualpa, an Andean man recounted the tale to the Spanish viceroy taking charge of the region whilst on his…
-
MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Uncovering Potential for Iska Iska to Become ‘Bonanza Style’ Bolivian Polymetallic Discovery
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) today announced assay results from eight additional diamond drill holes from its ongoing drilling program at the Iska Iska silver-tin polymetallic project in the Potosi Department, southern…
-
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Pipeline Focused on Creating Innovative Immunotherapeutic Products for Treating Underserved Infectious and Autoimmune Diseases
BiondVax Pharmaceuticals (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious diseases and autoimmune diseases – with a primary focus on diseases underserved…
-
EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Leads the Way Towards a Renewable Energy-Powered Future Within Canada
The United Nations Framework Convention on Climate Change – better known as COP27 – is taking place in Egypt’s Sharm el-Sheikh amidst one of the most significant climate emergencies ever experienced by man. A growing…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) 1-for-30 Reverse Stock Split Now in Place
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has announced a 1-for-30 reverse split of its common…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Investigation of DehydraTECH-CBD’s Potential Therapeutic Value for Diabetes and Defmentia with New Studies
Lexaria Bioscience (NASDAQ: LEXX) just announced two notable studies, DEM-A22-1, and DIAB-A22-1, on dementia and diabetes, respectively, scheduled for completion in January 2023. The studies seek a deeper understanding of the company’s patented DehydraTECH(TM)-processed CBD…
-
MissionIRNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Featured in Equity Research Reports
Aditxt (NASDAQ: ADTX), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, was featured in recent equity research reports published by H.C. Wainwright & Co. Titled…
-
Correlate Infrastructure Partners Inc. (CIPI) Helps Clients Achieve ESG Goals Through Proprietary Analytics, Advisement
Environmental, social and governance (“ESG”) responsibility has come to define corporate attention to climate change and steady drive toward clean energy adoption. While nearly a decade has passed since some 200 international entities and their…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K1 Technology Deployed for Transit System Client
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, has announced that an existing California-based transit client signed a contract to upgrade 97 of its parking lot emergency call boxes with the Knightscope K1…
-
MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) to Participate in Upcoming One-on-One Investor Conference
FingerMotion (NASDAQ: FNGR) CEO Martin Shen is scheduled to participate in one-on-one meetings during the Benchmark Company’s 11th annual Discovery One-on-One Investor Conference. The one-day event is scheduled for Dec. 1, 2022, in New York…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Q3 2022 Financial Results
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, released its financial and operating results for the third quarter and nine months ended Sept. 30, 2022. Among the…
-
MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Featured in Recent Power Play Interview
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, was spotlighted during a recent interview released by…
-
European Clinical Trial Site Expansion for CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Brain Cancer Drug Candidate Drives Patient Enrollment
Innovative brain tumor therapy developer CNS Pharmaceuticals (NASDAQ: CNSP) is reporting continued expansion of the number of clinical site launches for its evaluation of the company’s lead product candidate for treating recurrent glioblastoma multiforme (“GBM”).…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Seeking to Solve Unmet Need for GBM Treatment
CNS Pharmaceuticals (NASDAQ: CNSP) is an oncology drug development company specializing in developing anti-cancer drugs for the treatment of primary and metastatic brain and central nervous system cancer. “The first half of fiscal 2022 saw…
-
MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Bridging Gap Between Lidar Concept and Deployment with NVIDIA DRIVE Sim(TM)
Cepton (NASDAQ: CPTN) recently teamed up with NVIDIA to add its lidars into NVIDIA DRIVE Sim(TM) – an end-to-end simulation platform for large-scale, accurate multi-sensor simulation that supports autonomous driving development and validation from concept…
-
MissionIRNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Exec Featured in New Article
Correlate Infrastructure Partners (OTCQB: CIPI) director of corporate business development, Jason Loyet, is featured in a recent article. The article, titled “Get to Know Jason Loyet,” is a Q&A-format piece that provides an overview of…
-
HeartBeam Inc. (NASDAQ: BEAT) Announces New Chief Medical Officer
New Chief Medical Officer will play a major role in defining best paths to adoption, clinical strategies, and partnerships Dr. Fitzgerald serves as director of the Center for Cardiovascular Technology and of the Cardiovascular Core…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Trusted by the Game’s Elite: Newton Golf Company Inc. (NASDAQ: NWTG) Reaches New Milestone
- MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Paves Way to Redefine Cardiac Care
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Leads U.S. Effort to Reduce REE Dependence with Transformative Technology
- PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), Announces $1.74 Million Grant to Advance Nova Scotia Community Solar Projects, for Which PowerBank is Lead Developer
- MissionIRNewsBreaks – Massimo Group (NASDAQ: MAMO) Showcases New Products and Growth Strategy at Mid-States 2025 Rendezvous